OMER Q3 2018 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$821M

Q3 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M-78.7% YoY

Gross Profit

$5M99.2% margin

Operating Income

-$35M-769.1% margin

Net Income

-$39M-856.6% margin

EPS (Diluted)

$-0.81

QoQ Revenue Growth

+178.4%

Cash Flow

Operating Cash Flow

-$37M

Free Cash Flow

-$37M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$76M

Total Liabilities

$165M

Stockholders' Equity

-$89M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$22M	-78.7%
Gross Profit	$5M	$21M	-78.7%
Operating Income	-$35M	-$5M	-593.6%
Net Income	-$39M	-$7M	-427.6%